STING pathway expression in low‐grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?

Ovarian carcinoma histotypes are distinct diseases with variable clinical outcomes and response to treatment. There is a need for new subtype‐specific treatment modalities, especially for women with widespread and chemo‐resistant disease. Stimulator of interferon genes (STING) is a part of the cGAS–...

Descripción completa

Detalles Bibliográficos
Autores principales: Huvila, Jutta, Cochrane, Dawn R, Ta, Monica, Chow, Christine, Greening, Kendall, Leung, Samuel, Karnezis, Anthony N, DiFeo, Analisa, Huntsman, David G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503889/
https://www.ncbi.nlm.nih.gov/pubmed/34138519
http://dx.doi.org/10.1002/cjp2.230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503889/
https://www.ncbi.nlm.nih.gov/pubmed/34138519
http://dx.doi.org/10.1002/cjp2.230

Ejemplares similares